Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young"

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 17, Issue 6, 2007, Pages 468-472

  Migliaresi, Paola ^a   Celentano, Aldo ^a,b   Palmieri, Vittorio ^a   Pezzullo, Salvatore ^a   Martino, Stefania ^a   Bonito, Manuela ^a   Guillaro, Bruno ^c   Brancati, Ciro ^c   Di Minno, Giovanni ^a,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Orthopedic Traumatologic Center   (Italy)

^c Italian Society of Family Doctors (SIMG)   (Italy)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Epidemiology; Juvenile; Myocardial infarction; Risk factors

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DIABETES MELLITUS; EDUCATIONAL STATUS; EVALUATION; FEMALE; HEALTH PROMOTION; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; ITALY; LIFESTYLE; MALE; MIDDLE AGED; OBESITY; PATIENT EDUCATION; QUESTIONNAIRE; RISK; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL;

ADULT; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DIABETES COMPLICATIONS; EDUCATIONAL STATUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; HYPERCHOLESTEROLEMIA; ITALY; LIFE STYLE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; ODDS RATIO; PATIENT EDUCATION; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 34447573687     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2006.01.010     Document Type: Article

References (31)

1. Grundy S.M., Pasternak R., Greenland P., Smith Jr. S., and Fuster V. AHA/ACC scientific statement: assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 34 (1999) 1348-1359
2. Menotti A., Lanti M., Agabiti-Rosei E., Carratelli L., Cavera G., Dormi A., et al. Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies. Nutr Metab Cardiovasc Dis 15 (2005) 426-440
3. Imazio M., Bobbio M., Bergerone S., Barlera S., and Maggioni A.P. Clinical and epidemiological characteristics of juvenile myocardial infarction in Italy: the GISSI experience. G Ital Cardiol 28 (1998) 505-512
4. Celentano A., Palmieri V., Panico S., Russo C., Arezzi E., Pezzullo S., et al. Individuals' cardiovascular risk profile projected by family doctors and individuals' knowledge of cardiovascular risk factors: a challenge for primary prevention. The cardiovascular risk prevention project "Help Your Heart Stay Young". Ital Heart J 6 (2005) 557-564
5. Mosca L., Ferris A., Fabunmi R., and Robertson R.M. Tracking women's awareness of heart disease: an American Heart Association national study. Circulation 109 (2004) 573-579
6. Celentano A., Panico S., Palmieri V., Guillaro B., Brancati C., Di Palma E.N., et al. Citizens and family doctors facing awareness and management of traditional cardiovascular risk factors: results from the Global Cardiovascular Risk Reduction Project (Help Your Heart Stay Young Study). Nutr Metab Cardiovasc Dis 13 (2003) 211-217
7. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 854 (1995) 1-452
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment panel III). JAMA 19 (2003) 2486-2497
9. Haffner S.M., Mykkanen L., Festa A., Burke J.P., and Stern M.P. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation 101 (2000) 975-980
10. Tong W., Lai H., Yang C., Ren S., Dai S., and Lai S. Age, gender and metabolic syndrome-related coronary heart disease in U.S. adults. Int J Cardiol 104 (2005) 288-291
11. Reinehr T., Andler W., Denzer C., Siegried W., Mayer H., and Wabitsch M. Cardiovascular risk factors in overweight German children and adolescents: relation to gender, age and degree of overweight. Nutr Metab Cardiovasc Dis 15 (2005) 181-187
12. de Simone G., Palmieri V., Bella J.N., Celentano A., Hong Y., Oberman A., et al. Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study. J Hypertens 20 (2002) 323-331
13. Palmieri V., de Simone G., Arnett D.K., Bella J.N., Kitzman D.W., Oberman A., et al. Relation of various degrees of body mass index in patients with systemic hypertension to left ventricular mass, cardiac output, and peripheral resistance (The Hypertension Genetic Epidemiology Network Study). Am J Cardiol 88 (2001) 1163-1168
14. Chinali M., Devereux R.B., Howard B.V., Roman M.J., Bella J.N., Liu J.E., et al. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol 93 (2004) 40-44
15. Palmieri V., Celentano A., Roman J.M., de Simone G., Lewis M.R., Best L., et al. Fibrinogen and preclinical echocardiographic target organ damage. The Strong Heart Study. Hypertension 38 (2001) 1068-1074
16. Palmieri V., Celentano A., Roman M.J., de Simone G., Best L., Lewis M.R., et al. Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study. Am Heart J 145 (2003) 467-474
17. Vakili B.A., Okin P.M., and Devereux R.B. Prognostic implications of left ventricular hypertrophy. Am Heart J 141 (2001) 334-341
18. Lim H.S., Lip G.Y., Beevers D.G., and Blann A.D. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension. Eur J Clin Invest 35 (2005) 324-329
19. Stern M.P., Williams K., Gonzalez-Villalpando C., Hunt K.J., and Haffner S.M. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?. Diabetes Care 27 (2004) 2676-2681
20. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1998) 1414-1431
21. Palmieri V., Bella J.N., Arnett D.K., Liu J.E., Oberman A., Schuck M.Y., et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) Study. Circulation 103 (2001) 102-107
22. Liu J.E., Palmieri V., Roman M.J., Bella J.N., Fabsitz R., Howard B.V., et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 37 (2001) 1943-1949
23. Juhan-Vague I., Morange P.E., Frere C., Aillaud M.F., Alessi M.C., Hawe E., et al. The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study. J Thromb Haemost 1 (2003) 2322-2329
24. Assmann G., Cullen P., Fruchart J.C., Greten H., Naruszewicz M., Olsson A., et al. Implications of emerging risk factors for therapeutic intervention. Nutr Metab Cardiovasc Dis 15 (2005) 373-381
25. Danesh J., Lewington S., Thompson S.G., Lowe G.D., Collins R., Kostis J.B., et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 294 (2005) 1799-1809
26. Atherosclerosis TaVBISG. No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107 (2003) 1117-1122
27. Giampaoli S., Palmieri L., Mattiello A., and Panico S. Definition of high risk individuals to optimise strategies for primary prevention of cardiovascular diseases. Nutr Metab Cardiovasc Dis 15 (2005) 79-85
28. Pringle M. Current targets: where are we today?. Heart 89 Suppl. 2 (2003) ii10-ii12
29. Hobbs F.D., and Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract 19 (2002) 596-604
30. Doughty M., Mehta R., Bruckman D., Das S., Karavite D., Tsai T., et al. Acute myocardial infarction in the young - The University of Michigan experience. Am Heart J 143 (2002) 56-62
31. Mukherjee D., Hsu A., Moliterno D.J., Lincoff A.M., Goormastic M., and Topol E.J. Risk factors for premature coronary artery disease and determinants of adverse outcomes after revascularization in patients < or =40 years old. Am J Cardiol 92 (2003) 1465-1467